Cmv Sentence Examples

Young patients with negative serology for CMV, who may be candidates for bone marrow transplantation, should receive CMV negative blood products.

In the meantime, the NBS will continue to provide CMV seronegative components when requested for appropriate recipients.

While she was still battling oral cancer, her official cause of death was listed as "cardiopulmonary arrest due to liver failure and CMV hepatitis."

In children, ITP is usually triggered by a virus infection, most often rubella, chickenpox, measles, cytomegalovirus (CMV), or Epstein-Barr virus (EBV).

Specific diagnostic tests for autoimmune diseases and viruses (CMV, EBV, and rheumatoid factor or RF) may be performed.

It can be transmitted through body secretions, as well as by sexual contact; some newborns acquire CMV through the mother's breast milk.

About 1 to 2.2 percent of newborns in the United States are infected with CMV.

Surviving infants with CMV may suffer from hearing problems (15%) or mental retardation (30%).

Newborns who acquire CMV during the birth process or shortly after birth may develop pneumonia, hepatitis, or various blood disorders.

A diagnosis of CMV is usually confirmed by culturing the virus in a sample of the infant's urine.

Cytomegalovirus (CMV)-A common human virus causing mild or no symptoms in healthy people, but permanent damage or death to an infected fetus, a transplant patient, or a person with HIV.

Several maternal-fetal infections are known to increase the risk for CP, including rubella (German measles, now rare in the United States), cytomegalovirus (CMV), and toxoplasmosis.

Cytomegalovirus (CMV) is a virus related to the group of herpes viruses.

Infection with CMV can cause no symptoms or can be the source of serious illness in people with weak immune systems.

It is believed that about 85 percent of the adults in the United States have been infected by CMV at some point in their lives.

Because CMV can cross the placental barrier, initial infection in a pregnant woman can lead to infection of the developing baby.

In the United States, about 40 to 60 percent of all adults in the middle- and upper-socioeconomic classes show antibody proof of prior infection with CMV; antibody proof is as high as 80 percent in adults in the lower socioeconomic class.

Worldwide, about 0.2 to 2.2 percent of all babies are born with congenital CMV infection.

Of those babies born with congenital CMV infection, about 10 percent to 20 percent ultimately suffer form hearing impairment, eye damage, or problems with intellectual or motor function.

Babies can be born infected with CMV, either becoming infected in the uterus (congenital infection) or during birth (from infected cervical secretions).

Like other herpes viruses, CMV remains inactive (dormant) within the body for life after the initial infection.

Some of the more serious types of CMV infections occur in people who have been harboring the dormant virus, only to have it reactivate when their immune system is stressed.

In a healthy person, initial CMV infection often occurs without symptoms and is rarely noticed.

Occasionally, a first-time infection with CMV may cause a mild illness called mononucleosis.

About 8 percent of all mononucleosis cases are due to CMV infection.

A similar infection, though slightly more serious, may occur two to four weeks after receiving a blood transfusion containing CMV.

In people with weakened immune systems, CMV infection can cause more serious and potentially life-threatening illnesses.

Babies who contract CMV from their mothers during birth rarely develop any illness from these infections.

Infants born prematurely who become CMV infected during birth have a greater chance of complications, including pneumonia, hepatitis, decreased blood platelets.

However, an unborn baby is at great risk for serious problems when the mother becomes infected with CMV for the first time while pregnant.

A 2003 report found that pregnant women 25 years of age and older who are immune to CMV are much less likely to pass the virus to their babies than younger women who have never been exposed to CMV.

Body fluids or tissues can be tested to reveal CMV infection.

However, this information is not always particularly helpful because CMV stays dormant in the cells for life.

Tests to look for special immune cells (antibodies) that are directed specifically against CMV are useful in proving that a person has been infected with CMV.

However, these tests do not give any information regarding when the CMV infection first occurred.

Ganciclovir and foscarnet are antiviral medications that have been used to treat patients with weak immune systems who develop a serious illness from CMV (including retinitis).

As of 1998, research was still being done to try to find useful drugs to treat newborn babies suffering from congenital infection with CMV.

Antiviral drugs are not used to treat CMV infection in otherwise healthy patients because the drugs have significant side effects that outweigh their benefits.

In 2003, researchers in Europe announced a new compound that appeared to be highly effective against CMV infections.

Prognosis in healthy people with CMV infection is excellent.

About 0.1 percent of all newborn babies have serious damage from CMV infection occurring while they were developing in the uterus.

About 50 percent of all transplant patients develop severe illnesses due to reactivation of dormant CMV infection.

Prevention of CMV infection in the normal, healthy person involves good hand washing.

Blood products can be screened or treated to insure that they do not contain CMV.

In 2003, a new high-dose prophylactic (preventive) treatment was being tested to reduce CMV risk in stem cell transplant recipients.

Cytomegalovirus (CMV) is a common virus in the herpes virus family.

In adults, CMV may cause mild symptoms of swollen lymph glands, fever, and fatigue.

Infants can become infected with CMV while still in the uterus if the mother becomes infected or develops a recurrence of the infection during pregnancy.

Although most infants exposed to CMV before birth develop normally and do not show any symptoms, as many as 6,000 infants who were exposed to CMV before birth are born with serious complications each year.

Past or recent infection with cytomegalovirus (CMV) can be identified by antibody tests and CMV can be grown from body fluids.

Exposure to CMV can be serious and even life threatening for mothers and infants whose immune systems are compromised, for example, those receiving chemotherapy or who have HIV/AIDS.

Those infants who develop birth defects after CMV exposure may have serious, lifelong complications.

German measles (Rubella) and cytomegalovirus (CMV) are examples of maternal infections that may cause birth defects in the unborn child.